Inflammation: canakinumab for the cryopyrin-associated periodic syndromes

Nat Rev Rheumatol. 2009 Oct;5(10):529-30. doi: 10.1038/nrrheum.2009.195.
No abstract available

Publication types

  • News

MeSH terms

  • Antibodies, Monoclonal / adverse effects
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Clinical Trials, Phase III as Topic
  • Cryopyrin-Associated Periodic Syndromes / drug therapy*
  • Cryopyrin-Associated Periodic Syndromes / metabolism
  • Cryopyrin-Associated Periodic Syndromes / pathology
  • Humans
  • Immunologic Factors / adverse effects
  • Immunologic Factors / therapeutic use*
  • Interleukin-1beta / antagonists & inhibitors*
  • Interleukin-1beta / metabolism

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Immunologic Factors
  • Interleukin-1beta
  • canakinumab